|Bid||216.04 x 900|
|Ask||222.44 x 1100|
|Day's range||214.87 - 218.66|
|52-week range||174.60 - 234.30|
|Beta (5Y monthly)||0.96|
|PE ratio (TTM)||44.93|
|Forward dividend & yield||1.80 (0.78%)|
|Ex-dividend date||09 Feb 2023|
|1y target est||N/A|
S&P Dow Jones and MSCI will reclassify the Global Industry Classification Standard structure after the close on 17 March. These sector ETFs will be impacted.
There is nothing like a bear market to emphasize the importance of investing in solid, reliable, and steady companies that can deliver consistent revenue and earnings for a long time. Two such companies are AstraZeneca (NASDAQ: AZN) and Visa (NYSE: V). U.K.-based AstraZeneca is a drugmaker with a vast, diversified portfolio of over three-dozen products across six major segments.
These three stocks have had average annual earnings growth of more than 15% during the past five years.